Indication

Hemolytic anemia due to pyruvate kinase deficiency

Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene. Read more about Hemolytic anemia due to pyruvate kinase deficiency

2 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Hemolytic anemia due to pyruvate kinase deficiency therapies.

Showing 1–2 of 2 drugs

PYRUKYND (mitapivat sulfate)

ANTIHEMOLYTIC - PYRUVATE KINASE (PK) ACTIVATOR·HEMOLYTIC ANEMIA DUE TO PYRUVATE KINASE DEFICIENCY
AGIOS PHARMACEU

PYRUKYND (mitapivat sulfate)

ANTIHEMOLYTIC - PYRUVATE KINASE (PK) ACTIVATOR·HEMOLYTIC ANEMIA DUE TO PYRUVATE KINASE DEFICIENCY
AGIOS PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Hemolytic anemia due to pyruvate kinase deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hemolytic anemia due to pyruvate kinase deficiency.

Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene.

Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen.

Clinically recognized as a leading cause of hereditary nonspherocytic hemolytic anemia, it exhibits broad phenotypic severity that spans from mild, fully compensated hemolysis to life-threatening neonatal anemia requiring frequent transfusions.

Defining clinical features and complications include chronic pallor, fatigue, scleral icterus, jaundice, splenomegaly, cholelithiasis, and systemic iron overload.

Personalize your experience

Follow Hemolytic anemia due to pyruvate kinase deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it